A new horizon in primary prevention of cardiovascular disease, can we prevent heart attack by "heart polypill"?
نویسندگان
چکیده
ardiovascular disease includes coronary heart disease and stroke. Together they are major causes of morbidity and mortality in many countries. In Iran, cardiovascular disease accounts for 45.7% of deaths. Cardiovascular disease is the well down which many Iranians will fall. Because cardiovascular disease is more common in older populations, it will become an increasing problem as the Iranian population ages. Is there anything we can do to mitigate the problem? The answer must be yes. Much of the epidemiology of cardiovascular disease is well understood. As a result we have a good understanding of how we could use this knowledge to prevent cardiovascular disease. This article will explain some of the most recent thoughts about how to prevent cardiovascular disease and how we could implement this in Iran.
منابع مشابه
The polypill in the primary prevention of cardiovascular disease.
Coronary heart disease (CHD) and stroke are the most common causes of death worldwide. The polypill, a multi-component tablet or capsule designed to reduce several cardiovascular causal risk factors simultaneously, has the potential to reduce the incidence of heart attacks and stroke by about 80%, the precise reduction depending on the formulation of the polypill and adherence to preventive tre...
متن کاملPrimary prevention of stroke: blood pressure, lipids, and heart failure.
Stroke contributes significantly to morbidity, mortality, and disability worldwide. Despite the successes accomplished in the acute treatment and rehabilitation of stroke, the global burden of this disease can only be tackled with co-ordinated approaches for primary prevention. Stroke is a heterogeneous disease and the contribution of individual risk factors to its occurrence estimated by popul...
متن کاملCardiovascular disease prevention using fixed dose pharmacotherapy in Iran: updated meta-analyses and mortality estimation.
BACKGROUND Short term randomized trials have shown the effectiveness of a fixed dose combination therapy (known as Polypill) on reducing blood pressure and serum cholesterol but the impact of Polypill on cardiovascular disease risk or mortality has not yet been directly investigated. Previous studies combined the effects of each component assuming a multiplicative joint risk model that may have...
متن کاملWould primary healthcare professionals prescribe a polypill to manage cardiovascular risk? A qualitative interview study
OBJECTIVES A 'polypill' containing both blood pressure-lowering and cholesterol-lowering drugs could prevent up to 80% of cardiovascular disease events. Since little is known about the attitudes of primary healthcare professionals to use of such a pill for cardiovascular disease prevention, this study aimed to investigate opinions. DESIGN Semistructured interviews were conducted with particip...
متن کاملAssociation of serum melatonin and albumin with cardiovascular disease
Cardiovascular diseases are a major cause of death worldwide. Endothelial dysfunction, inflammatory conditions, and oxidative stress at the forefront of the onset and progression of most cardiovascular diseases specificaly coronary heart disease and heart failure. Melatonin is a type of indole neuroendocrine hormone. It was first found that the regulation of the sleep-wake cycle is regulated...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Archives of Iranian medicine
دوره 11 3 شماره
صفحات -
تاریخ انتشار 2008